Table 3 Clinical characteristics of subjects included in longitudinal studies.
Baseline | After weight lost | Variation, % | P | |
|---|---|---|---|---|
BMI (kg/m2) | 32.63 ± 4.28 | 29.86 ± 4.38 | −8.49 | 0.001 |
Waist circumference (cm) | 103.67 ± 9.95 | 100.63 ± 9.65 | −2.93 | 0.000 |
Waist-to-hip ratio | 0.93 ± 0.05 | 0.91 ± 0.05 | −2.15 | 0.013 |
Fasting glucose (mmol/L) | 5.35 ± 0.63 | 5.14 ± 0.40 | −3.93 | 0.408 |
Fasting insulin (μU/mL) | 15.48 ± 11.10 | 9.79 ± 6.16 | −36.76 | 0.015 |
HOMA-β (%) | 168.59 ± 100.71 | 116.97 ± 49.34 | −30.62 | 0.066 |
HOMA-IR | 3.82 ± 3.04 | 2.30 ± 1.68 | −39.79 | 0.019 |
lncRNA-p5549 | 0.15 ± 0.08 | 0.19 ± 0.10 | 26.67 | 0.355 |
lncRNA-p21015 | 0.49 ± 0.34 | 0.86 ± 0.69 | 75.51 | 0.169 |
lncRNA-p19461 | 0.40 ± 0.20 | 1.68 ± 0.63 | 320.00 | 0.001 |